Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
Pokiniewski, Katie A.
Chin, Mario P. S.
GroupSol Sherry Thrombosis Research Center (Temple University)
Cardiovascular Research Center (Temple University)
DepartmentMicrobiology and Immunology
Permanent link to this recordhttp://hdl.handle.net/20.500.12613/8768
MetadataShow full item record
AbstractAdeno-associated virus (AAV) vectors have emerged as a safe and efficient gene therapy platform. One complication is that a significant amount of empty particles have always been generated as impurities during AAV vector production. However, the effects of such particles on AAV vector performance remain unclear. Here we systemically evaluated the biological properties of three types of “empty” AAV particles: syngeneic pseudo-vectors with partial AAV genomes derived from DNA of the corresponding full particles, allogeneic pseudo-vectors with partial genomes different from the corresponding full particles, and null pseudo-vectors with no DNA inside the capsids. The syngeneic particles in excess increased the corresponding full AAV vector transgene expression both in vivo and in vitro. However, such effects were not observed with null or allogeneic particles. The observed differences among these pseudo-AAV particles may be ascribed to the syngeneic pseudo-vector DNA facilitating the complementary DNA synthesis of the corresponding full AAV particles. Our study suggests that the DNA content in the pseudo-vectors plays a key role in dictating their effects on AAV transduction. The effects of residual “empty” particles should be adequately assessed when comparing AAV vector performance. The syngeneic AAV pseudo-vectors may be used to enhance the efficacy of gene therapy.
Citation to related workCell Press
Has partMolecular Therapy - Methods and Clinical Development, Vol. 4
ADA complianceFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact email@example.com